TUDOR INVESTMENT CORP ET AL - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 140 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.6%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,554,465
+578.8%
94,210
+2163.6%
0.02%
+220.0%
Q1 2022$229,000
+13.9%
4,162
+195.2%
0.01%
-16.7%
Q4 2020$201,000
-29.2%
1,410
-65.3%
0.01%
-57.1%
Q2 2020$284,000
+5.6%
4,063
-47.2%
0.01%
-41.7%
Q1 2020$269,000
-85.6%
7,693
-74.2%
0.02%
-71.4%
Q4 2019$1,871,000
+310.3%
29,763
+118.7%
0.08%
+425.0%
Q3 2019$456,00013,6080.02%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders